AivoCode
Aman Mann is the Co-Founder and CEO of AivoCode. Aman has also served as a Life Science Analyst at Tech Coast Angels, a Research Assistant Professor at Sanford Burnham Medical Research Institute, a Research Scholar at M.D Anderson Cancer Center, an Executive Chair at Sanford Burnham Science Network, and a Visiting Research Fellow at Methodist Hospital Research Institute. Aman began their career as a Summer Intern at the University of Debrecen in Hungary.
Aman Mann has a B.Tech and M.Tech in Biochemical Engineering and Biotechnology from the Indian Institute of Technology, Delhi. Aman also has a Doctor of Philosophy (PhD) in Biomedical Sciences, General from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences. Finally, they have a Micro MBA in Business Administration and Management, General from the University of California, San Diego - Rady School of Management.
Some individuals on their team include Erkki Ruoslahti - Co-Founder & Executive Chairman, Sazid Hussain - Co-Founder & CSO.
AivoCode
AivoCode is a neuroscience-focused biotech startup that is pioneering the development of innovative and broad platform technologies to improve the treatment and management of neurological diseases such as brain injury, Alzheimer’s disease, and other neurodegenerative disorders.